In the News: Canada Ejects Three Chinese Companies; CFIUS Enforcement and Penalty Guidelines; and First Metaverse IPO

November 09, 2022 | BY

Hugo Yeung &Josiah Wang

Three Chinese companies ordered out of Canada's lithium industry; CFIUS publishes first-ever enforcement and penalty guidelines; and China's metaverse IPO starts in Hong Kong.

Legislative Assembly of Ontario at Queens Park, Toronto. Credit: Andrés García/Adobe Stock

|

Chinese Mineral Companies to Divest from Canada

On November 2, Canada's industry and commerce regulator, Innovation, Science and Economic Development Canada (ISED), ordered three Chinese companies to divest their investments in Canada's critical mineral sector, primarily lithium.

The Investment Canada Act (ICA) sets out the multi-step national security review process for inbound foreign investment into sensitive industries. The three Chinese companies reviewed under the ICA are: Sinomine (Hong Kong) Rare Metals Resources Co., Limited, Chengze Lithium International Limited, and Zangge Mining Investment (Chengdu) Co., Ltd. In a statement, François-Philippe Champagne, Canada's Minister of Innovation, Science and Industry, emphasized that the government "will act decisively when investments threaten our national security and our critical minerals supply chains, both at home and abroad." He further adds that foreign investments are subject to review for national security concerns, and certain types of investment—such as those in the critical minerals sectors—receive enhanced scrutiny.

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]